Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...

More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new BioSpace employment ...

Prism aims to move ChatGPT into scientific writing as OpenAI signals plans to share in future profits. Some are warning against its pitfalls.

Under the MoU, Prognica Labs and MAHE will collaborate across multiple centres of excellence within MAHE, including Kasturba Medical College (KMC), Manipal School of Life Sciences (MSLS), Department ...

Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative ...

When pursuing a single drug candidate, chemists make many molecules. Pharmaceutical companies catalog and store these ...

Dr. Mobasher held several executive roles in industry, most recently CMO at BeiGeneIFLI contributed up to $9 million to Enterome’s private funding round in 2025Enterome has announced a series of ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Scientists have discovered a molecule that shrinks brain tumors in mice, raising hopes that the compound could one day become a pill to treat glioblastoma, one of the world’s most pernicious cancers.

Regulatory fast-track supports global approvals, McKinsey says Japan recorded 24 US Food and Drug Administration novel-drug approvals between 2015 and 2023, the highest total among Asian markets, ...

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...